FrancophonIA/ELRC3.0 huggingface dataset:
English: • Other medicines containing didanosine (for HIV infection): Taking Viread with other antiviral medicines that contain didanosine can raise the levels of didanosine in your blood and may reduce CD4 cell counts.
Croatian: • Drugi lijekovi koji sadrže didanozin (za infekciju virusom HIV-a): Uzimanjem Vireada s drugim antivirusnim lijekovima koji sadrže didanozin može Vam se povećati razina didanozina u krvi i smanjiti broj CD4 stanica.
English: Viread 33 mg/g granules are not suitable for the following groups:
Croatian: Viread 33 mg/g granule nisu pogodne za sljedeće skupine:
English: Pharmacokinetic modelling of single-dose pharmacokinetic data in non-HIV and non-HBV infected adult subjects with varying degrees of renal impairment was used to determine dose and dosing interval recommendations for adult subjects with varying degrees of renal impairment (see section 4.2).
Croatian: Farmakokinetički model podataka o farmakokinetici jednokratnih doza u odraslih ispitanika koji nisu bili zaraženi virusom HIV i hepatitisa B, a imali su oštećenje funkcije bubrega različitih stupnjeva primjenjivao se za određivanje preporuka za doze i intervale između doza za odrasle ispitanike s različitim stupnjevima oštećenja bubrega (vidjeti dio 4.2).
English: Do not use this medicine after the expiry date which is stated on the bottle and carton after {EXP}.
Croatian: Ovaj lijek se ne smije upotrijebiti nakon isteka roka valjanosti navedenog na boci i kartonskoj kutiji iza oznake „Rok valjanosti”.
English: • decreases in phosphate in the blood
Croatian: • smanjenje fosfata u krvi
English: The choice of Viread to treat antiretroviral-experienced patients with HIV-1 infection should be based on individual viral resistance testing and/or treatment history of patients.
Croatian: Odabir Vireada za liječenje bolesnika zaraženih virusom HIV-1 koji su već liječeni antiretrovirusnim lijekovima mora se temeljiti na individualnom ispitivanju virusne rezistencije i/ili prethodnom liječenju bolesnika.
English: In HIV Viread should always be used combined with other medicines to treat HIV infection.
Croatian: Kod HIV-a, Viread se uvijek treba primjenjivati u kombinaciji s drugim lijekovima za liječenje HIV-infekcije.
English: If you stop taking Viread
Croatian: Ako prestanete uzimati Viread
English: • If you are an adult and have problems with your kidneys, your doctor may advise you to reduce your daily dose of the granules.
Croatian: • Ako ste odrasla osoba i imate problema s bubrezima, možda će Vas liječnik uputiti da smanjite dnevnu dozu granula.
English: Viread 33 mg/g granules are only suitable for:
Croatian: Viread 33 mg/g granule pogodne su samo za:
English: Serum ALT should be persistently elevated for at least 6 months prior to treatment of paediatric patients with compensated liver disease due to HBeAg positive chronic hepatitis B; and for at least 12 months in patients with HBeAg negative disease.
Croatian: Serumski ALT treba biti kontinuirano povišen najmanje 6 mjeseci prije liječenje pedijatrijskih bolesnika s kompenziranom bolešću jetre uslijed HBeAg pozitivnog kroničnog hepatitisa B te najmanje 12 mjeseci u bolesnika s HBeAg negativnom bolešću.
English: Co-infection with HIV-1 and hepatitis B: Due to the risk of development of HIV resistance, tenofovir disoproxil should only be used as part of an appropriate antiretroviral combination regimen in HIV/HBV co-infected patients.
Croatian: Istovremena infekcija HIV-om tipa 1 i HBV-om: Zbog rizika od razvoja rezistencije HIV-a, tenofovirdizoproksil mora se primjenjivati samo u sklopu odgovarajućeg kombiniranog antiretrovirusnog liječenja kod bolesnika istovremeno inficiranih HIV-om/HBV-om.
English: If you have been told by your child's doctor that your child has an intolerance to some sugars, contact your child's doctor before they take this medicinal product.
Croatian: Ako Vam je djetetov liječnik rekao da Vaše dijete ne podnosi neke šećere, obratite se djetetovom liječniku prije uzimanja ovog lijeka.
English: HIV antibody testing should be offered to all HBV infected patients before initiating tenofovir disoproxil therapy (see below Co-infection with HIV-1 and hepatitis B).
Croatian: Općenito Testiranje na protutijela na HIV mora se preporučiti svim bolesnicima inficiranim HBV-om prije početka terapije tenofovirdizoproksilom (vidjeti niže navedeni odlomak Istovremena infekcija HIV-om tipa 1 i HBV-om).
English: • That there is an increased risk of renal disease in HIV and HBV infected patients associated with tenofovir disoproxil fumarate-containing products such as Viread
Croatian: • Da u bolesnika zaraženih HIV-om i HBV-om postoji povećan rizik od bubrežne bolesti povezan s lijekovima koji sadrže tenofovirdizoproksilfumarat, kao što je Viread
English: - In HBeAg positive patients without cirrhosis, treatment should be administered for at least 12 months after HBe seroconversion (HBeAg loss and HBV DNA loss with anti-HBe detection on two consecutive serum samples at least 3-6 months apart) is confirmed or until HBs seroconversion or there is loss of efficacy (see section 4.4).
Croatian: - Kod HBeAg pozitivnih bolesnika bez ciroze, liječenje se mora primjenjivati najmanje 12 mjeseci nakon potvrđene HBe serokonverzije (nestanak HBeAg i HBV DNK s detekcijom anti-HBe na dvama uzastopnim uzorcima seruma u razmaku od najmanje 3 do 6 mjeseci) ili sve do HBs serokonverzije ili do gubitka djelotvornosti (vidjeti dio 4.4).
English: In general, treatment responses to tenofovir disoproxil were similar for genotypes A, B, C and E [75-100% of subjects achieved HBV DNA < 400 copies/mL (69 IU/mL) at Week 48] with a lower response rate in subjects with genotype D infection (55%).
Croatian: Općenito su odgovori na liječenje tenofovirdizoproksilom bili slični za genotipove A, B, C i E [75­100% ispitanika postiglo je HBV DNK < 400 kopija/ml (69 IU/ml) u 48. tjednu] s manjom stopom odgovora u ispitanika s infekcijom genotipom D (55%).
English: This is to make sure that their medicine is fully effective, and to reduce the risk of developing resistance to the treatment.
Croatian: To je iz razloga da budete sigurni da je lijek koji uzima potpuno djelotvoran te da se smanji rizik od razvoja otpornosti na liječenje.
English: (4 subjects)
Croatian: (4 bolesnika)
English: Study GS-US-174-0103 was conducted in 266 (randomised and treated) HBeAg positive patients while study GS-US-174-0102 was conducted in 375 (randomised and treated) patients negative for HBeAg and positive for HBeAb.
Croatian: Ispitivanje GS-US-174-0103 provodilo se na 266 (randomiziranih i liječenih) bolesnika pozitivnih na HbeAg, a ispitivanje GS-US-174-0102 provodilo se na 375 (randomiziranih i liječenih) bolesnika negativnih na HbeAg i pozitivnih na HBeAb.
English: The active substance tenofovir disoproxil and its main transformation products are persistent in the environment.
Croatian: Ocjena utjecaja na okoliš Djelatna tvar tenofovirdizoproksil i njegovi glavni transformacijski produkti nisu razgradivi u okolišu.
English: HBsAg loss/seroconversion
Croatian: HBsAg nestanak/ serokonverzija
English: At weeks 96, 144, 192, 240, 288 and 384, viral suppression, biochemical and serological responses were maintained with continued tenofovir disoproxil treatment (see Tables 5 and 6 below).
Croatian: U 96., 144., 192., 240., 288. i 384. tjednu supresija virusa, i biokemijski i serološki odgovori bili su održani uz nastavak liječenja tenofovirdizoproksilom (vidjeti tablice 5 i 6
English: Talk to your doctor or pharmacist before taking Viread.
Croatian: Razgovarajte sa svojim liječnikom ili ljekarnikom prije uzimanja Vireada.
English: After oral administration of tenofovir disoproxil, tenofovir is distributed to most tissues with the highest concentrations occurring in the kidney, liver and the intestinal contents (preclinical studies).
Croatian: Nakon peroralne primjene tenofovirdizoproksila tenofovir se raspodjeljuje u većinu tkiva, kod čega su najviše koncentracije u bubregu, jetri i sadržaju crijeva
English: At weeks 96, 144, 192, 240, 288 and 384, viral suppression, biochemical and serological responses were maintained with continued tenofovir disoproxil treatment (see Tables 4 and 5 below).
Croatian: U 96., 144., 192., 240., 288. i 384. tjednu supresija virusa, i biokemijski i serološki odgovori bili su održani uz nastavak liječenja tenofovirdizoproksilom (vidjeti tablice 4 i 5
English: In children whose mothers took NRTIs during pregnancy, the benefit from the protection against HIVoutweighed the risk of side effects.
Croatian: U djece čije su majke tijekom trudnoće uzimale NRTI-jeve prevagnula je korist od zaštite protiv
English: Some examples include, but are not limited to, aminoglycosides, amphotericin B, foscarnet, ganciclovir, pentamidine, vancomycin, cidofovir or interleukin-2 (see section 4.4).
Croatian: amfotericin B, foskarnet, ganciklovir, pentamidin, vankomicin, cidofovir ili interleukin-2 (vidjeti dio 4.4).
English: High density polyethylene (HDPE) bottle with a polypropylene child-resistant closure containing 60 g of granules and a dosing scoop.
Croatian: Boca od polietilena visoke gustoće (HDPE) s polipropilenskim sigurnosnim zatvaračem za djecu, koja sadrži 60 g granula i mjernu žličicu.
English: Refer to section 2 “Viread contains lactose”.
Croatian: Pogledajte dio 2, „Viread sadrži laktozu”.
English: Total dose (mg) tenofovir disoproxil
Croatian: Ukupna doza (mg) tenofovirdizoproksila
English: • If you have taken Viread during your pregnancy, your doctor may request regular blood tests and other diagnostic tests to monitor the development of your child.
Croatian: • Ako ste Viread uzimali tijekom trudnoće, postoji mogućnost da liječnik zatraži redovito provođenje pretraga krvi i drugih dijagnostičkih pretraga kako bi pratio razvoj vašega djeteta.
English: If your child has a history of liver disease or chronic hepatitis B infection your child's doctor may conduct blood tests to monitor their liver function.
Croatian: Ako je Vaše dijete imalo bolest jetre ili kroničnu infekciju hepatitisom B, liječnik Vašeg djeteta možda će napraviti krvne pretrage da bi mogao pratiti funkciju jetre Vašeg djeteta.
English: HIV-1 and Chronic hepatitis B
Croatian: HIV-1 i kronični hepatitis B
English: In studies GS-US-174-0102 and GS-US-174-0103, after receiving double-blind treatment for 48 weeks (either tenofovir disoproxil 245 mg or adefovir dipivoxil 10 mg), patients rolled over with no interruption in treatment to open-label tenofovir disoproxil.
Croatian: U ispitivanjima GS-US-174-0102 i GS-US-174-0103 nakon uzimanja dvostruko slijepe terapije tijekom 48 tjedana (ili 245 mg tenofovirdizoproksila ili 10 mg adefovirdipivoksila) bolesnici su bez prekida liječenja prešli u otvoreno ispitivanje tenofovirdizoproksila.
English: • Talk to your child's doctor before your child stops taking Viread for any reason, particularly if your child is experiencing any side effects or they have another illness.
Croatian: • Razgovarajte s liječnikom Vašeg djeteta prije nego što iz bilo kojeg razloga Vaše dijete prestane uzimati Viread, osobito ako osjeti neke nuspojave ili dobije neku drugu bolest.
English: Response to treatment with tenofovir disoproxil was comparable in nucleos(t)ide-naïve (n = 20) and nucleos(t)ideexperienced (n = 32) patients, including lamivudine-resistant patients (n = 6).
Croatian: Odgovor na liječenje tenofovirdizoproksilom bio je usporediv u bolesnika koji prethodno nisu (n = 20) i onih koji jesu (n = 32) primali nukleoz(t)idne lijekove, uključujući bolesnike rezistentne na lamivudin (n = 6).
English: As Viread may cause renal damage monitoring of renal function is recommended (see sections 4.4 and 4.8 Summary of the safety profile).
Croatian: Oštećenje funkcije bubrega Pošto Viread može prouzročiti oštećenje bubrega, preporučuje se praćenje funkcije bubrega (vidjeti dijelove 4.4 i 4.8 Sažetak profila sigurnosti primjene).
English: • changes to your child's urine and back pain caused by kidney problems, including kidney failure
Croatian: • promjene svojstava mokraće i bol u leđima kod Vašeg djeteta uzrokovana tegobama s bubrezima, uključujući zatajenje bubrega
English: Experience in patients with compensated liver disease at 48 weeks (studies GS-US-174-0102 and GS-US-174-0103)
Croatian: Iskustva kod bolesnika s kompenziranom bolešću jetre tijekom 48 tjedana (ispitivanja GS-US-174-0102 i GS-US-174-0103)
English: • If your child has taken Viread during their pregnancy, your child's doctor may request regular blood tests and other diagnostic tests to monitor the development of the baby.
Croatian: • Ako je Vaše dijete uzimalo Viread tijekom trudnoće, postoji mogućnost da liječnik Vašeg djeteta zatraži redovito provođenje pretraga krvi i drugih dijagnostičkih pretraga kako bi pratio razvoj ploda.
English: In patients with end-stage renal disease (ESRD) (CrCl < 10 ml/min) requiring haemodialysis, between dialysis tenofovir concentrations substantially increased over 48 hours achieving a mean Cmax of 1,032 ng/ml and a mean AUC0-48h of 42,857 ng·h/ml.
Croatian: U bolesnika s bolešću bubrega u završnoj fazi (CrCl < 10 ml/min) kojima je potrebna hemodijaliza koncentracije tenofovira između dijaliza znatno su se povećale tijekom 48 sati i dosegle srednju vrijednost Cmax od 1032 ng/ml i srednju vrijednost AUC0-48h od 42.857 ng·h/ml.
English: Acute exacerbation of hepatitis has been reported in patients on treatment as well as in patients who have discontinued hepatitis B therapy (see section 4.4).
Croatian: Akutna egzacerbacija hepatitisa zabilježena je u bolesnika tijekom liječenja, kao i u onih koji su prekinuli terapiju hepatitisa B (vidjeti dio 4.4).
English: While taking Viread your child may still develop infections or other illnesses associated with HIV infection.
Croatian: I tijekom uzimanja Vireada u Vašeg djeteta može doći do razvoja infekcija i drugih bolesti povezanih s infekcijom virusom HIV-a.
English: Viread granules contain mannitol
Croatian: Viread granule sadrže manitol.
English: A pharmacokinetic study has been performed in non-HIV infected adult patients with various degrees of hepatic impairment.
Croatian: Provedeno je farmakokinetičko ispitivanje u odraslih bolesnika bez infekcije HIV-om koji su imali različiti stupanj oštećenja funkcije jetre.
English: Viread 33 mg/g granules Tenofovir disoproxil
Croatian: Viread 33 mg/g granule tenofovirdizoproksil
English: If your child stops taking Viread
Croatian: Ako Vaše dijete prestane uzimati Viread
English: Co-administration of Viread and didanosine is not recommended as this may result in an increased risk of adverse reactions (see section 4.5).
Croatian: Ne preporučuje se istovremena primjena Vireada i didanozina, jer to može rezultirati povećanim rizikom od nuspojava (vidjeti dio 4.5).
English: Liver flares are especially serious, and sometimes fatal in patients with decompensated liver disease.
Croatian: Hepatičke reaktivacije su posebno ozbiljne, a u bolesnika s dekompenziranom bolešću jetre mogu ponekad imati smrtni ishod.
English: Adults and adolescents aged 12 to < 18 years and weighing ≥ 35 kg:
Croatian: Odrasli i adolescenti u dobi od 12 do < 18 godina i tjelesne težine ≥ 35 kg:
English: Autoimmune disorders (such as Graves' disease and autoimmune hepatitis) have also been reported; however, the reported time to onset is more variable and these events can occur many months after initiation of treatment (see section 4.4).
Croatian: Autoimuni poremećaji (poput Gravesove bolesti i autoimunog hepatitisa) također su zabilježeni; međutim, prijavljeno vrijeme do nastupa poremećaja više varira i ti događaji mogu se pojaviti puno mjeseci nakon početka liječenja
English: 11l a Based upon Long Term Evaluation algorithm (LTE Analysis) - Patients who discontinued the study at any time prior to week 384 due to a protocol defined endpoint, as well as those completing week 384, are included in the denominator.
Croatian: 11l a Temelji se na algoritmu dugoročne promjene (LTE analiza) - Bolesnici koji su prekinuli sudjelovanje u ispitivanju bilo kada prije 384. tjedna zbog postizanja protokolom definirane mjere ishoda i oni koji su dovršili 384 tjedna liječenja uključeni su u nazivnik.
English: • If you are an adult and have problems with your kidneys, your doctor may advise you to take Viread less frequently.
Croatian: • Ako ste odrasla osoba i imate problema s bubrezima, možda će Vas liječnik uputiti da rjeđe uzimate Viread.
English: If your child is pregnant or breast-feeding, or they think they may be pregnant, ask your child's doctor or pharmacist for advice before they take this medicine.
Croatian: Ako je Vaše dijete trudno ili doji ili misli da bi moglo biti trudno, obratite se liječniku Vašeg djeteta ili ljekarniku za savjet prije nego što uzme ovaj lijek.
English: What you need to know before your child takes Viread
Croatian: Što morate znati prije nego što Vaše dijete počne uzimati Viread
English: The distribution of HBV genotypes at baseline was similar between the TDF and Placebo groups.
Croatian: Distribucija HBV genotipova na početku ispitivanja bila je slična u skupinami tenofovirdizoproksila i placeba.
English: Your child's doctor may also order blood tests during treatment to monitor how your child's kidneys work.
Croatian: Također liječnik Vašeg djeteta može zatražiti krvne pretrage i tijekom liječenja u cilju praćenja rada bubrega Vašeg djeteta.
English: Dose adjustments using tenofovir disoproxil 33 mg/g granules are recommended for patients with creatinine clearance < 50 ml/min.
Croatian: Prilagodba doziranja tenofovirdizoproksila 33 mg/g granula preporučuje se za bolesnike s klirensom kreatinina < 50 ml/min.
English: Talk to your child's doctor or pharmacist before giving Viread.
Croatian: Razgovarajte sa liječnikom Vašeg djeteta ili ljekarnikom prije nego što mu date Viread.
English: If your child misses a dose, work out how long since they should have taken it.
Croatian: Ako propusti dozu, izračunajte koliko je proteklo od vremena kad ju je trebalo uzeti.
English: The results indicate that patients whose HIV expressed 3 or more thymidine-analogue associated mutations (TAMs) that included either the M41L or L210W reverse transcriptase mutation showed reduced response to tenofovir disoproxil 245 mg therapy.
Croatian: Rezultati pokazuju da su bolesnici čiji je HIV izražavao 3 ili više mutacija povezanih s analogom timidina (TAM) koje su uključivale mutaciju reverzne transkriptaze M41L ili L210W
English: Following the first dose of tenofovir disoproxil in fed patients, the median Cmax in serum ranged from 213 to 375 ng/ml.
Croatian: Nakon prve doze tenofovirdizoproksila primijenjene nahranjenim bolesnicima, medijan Cmax u serumu kretao se u rasponu od 213 do
English: Monitoring of renal function is recommended for patients receiving Viread (see section 4.4).
Croatian: Preporučuje se praćenje funkcije bubrega u bolesnika koji primaju Viread (vidjeti dio 4.4).
English: Do not give a double dose to make up for a forgotten tablet.
Croatian: Nemojte dati dvostruku dozu kako biste nadoknadili zaboravljenu tabletu.
English: Cumulatively, there were 4 patients who experienced a viremic episode (HBV DNA>400 copies/ml) at their last timepoint on TDF.
Croatian: Kumulativno, 4 bolesnika na tenofovirdizoproksilu imala su viremijsku epizodu (HBV DNK > 400 kopija/ml) u posljednjoj vremenskoj točki.
English: Keep the granules bottle with you so that you can easily describe what you have taken.
Croatian: Sa sobom ponesite bočicu s granulama kako bi lakše opisali što ste uzeli.
English: Gender Limited data on the pharmacokinetics of tenofovir in women indicate no major gender effect.
Croatian: Ograničeni farmakokinetički podaci u žena ne ukazuju na veće učinke vezane uz spol.
English: Table 11: Mean (± SD) tenofovir pharmacokinetic parameters by age groups for paediatric patients
Croatian: Tablica 11: Srednje (± SD) vrijednosti farmakokinetičkih parametara tenofovira po dobnim skupinama pedijatrijskih bolesnika
English: Median HBV DNA reduction from baseline c
Croatian: Medijan smanjenja HBV DNK od početne vrijednostic
English: Adjustments of the daily dose of tenofovir disoproxil 33 mg/g granules are recommended in patients with moderate (creatinine clearance 30-49 ml/min) or severe (creatinine clearance < 30 ml/min) renal impairment based on modelling of single-dose pharmacokinetic data in HIV negative and non-HBV infected subjects with varying degrees of renal impairment, including end-stage renal disease requiring haemodialysis.
Croatian: Prilagodbe dnevnih doza tenofovirdizoproksila 33 mg/g granula preporučuju se u bolesnika s umjerenim (klirens kreatinina 30-49 ml/min) ili teškim (klirens kreatinina < 30 ml/min) oštećenjem funkcije bubrega na temelju modela podataka o farmakokinetici jednokratnih doza u ispitanika koji su bili HIV negativni i koji nisu bili zaraženi virusom hepatitisa B, a imali su oštećenje funkcije bubrega različitih stupnjeva, uključujući i bubrežnu bolest u završnoj fazi za koju je bila potrebna hemodijaliza.
English: High density polyethylene (HDPE) bottle with a polypropylene child-resistant closure containing 30 film-coated tablets and a silica gel desiccant.
Croatian: Boca od polietilena visoke gustoće (HDPE) s polipropilenskim sigurnosnim zatvaračem za djecu, koja sadrži 30 filmom obloženih tableta i silika gel kao sredstvo za sušenje.
English: At week 72, 96% (27/28) of immune-active patients (HBV DNA ≥ 105 copies/ml, serum ALT > 1.5 x ULN) in the tenofovir disoproxil treatment group and 0% (0/32) of patients in the placebo group had HBV DNA < 400 copies/ml.
Croatian: U 72. tjednu, 96% (27/28) imunološki aktivnih bolesnika (HBV DNK ≥ 105 kopija/ml, ALT u serumu > 1,5 x GGN) u skupini liječenoj tenofovirdizoproksilom i 0% (0/32) bolesnika u skupini koja je primala placebo imalo je HBV DNK < 400 kopija/ml.
English: Tenofovir disoproxil Metabolism and nutrition disorders: Very common:
Croatian: Poremećaji metabolizma i prehrane: Vrlo često:
English: Co-administration of tenofovir disoproxil and didanosine at a dose of 400 mg daily has been associated with a significant decrease in CD4 cell count, possibly due to an intracellular interaction increasing phosphorylated (i.e. active) didanosine.
Croatian: Istovremena primjena tenofovirdizoproksila i didanozina u dozi od 400 mg na dan bila je povezana sa značajnim smanjenjem broja CD4 stanica, vjerojatno zbog unutarstanične interakcije koja povećava količinu fosforiliranog (tj.
English: If you have advanced HIV infection (AIDS) and have an infection, you may develop symptoms of infection and inflammation or worsening of the symptoms of an existing infection once treatment with Viread is started.
Croatian: Ako imate uznapredovali oblik HIV infekcije (AIDS) i imate neku infekciju, u Vas se mogu nakon započinjanja liječenja Vireadom razviti simptomi infekcije i upale ili pogoršanje simptoma postojeće infekcije.
English: Confirmed increase in serum creatinine ≥ 0.5 mg/dl from baseline or confirmed serum phosphate of < 2 mg/dl n (%)b
Croatian: ≥ 0,5 mg/dl od početne vrijednosti ili potvrđene fosfate u serumu < 0,2 mg/dl n (%)b
English: Before starting treatment, your child's doctor may order blood tests to assess your child's kidney function.
Croatian: Prije početka liječenja, liječnik Vašeg djeteta možda će zatražiti krvne pretrage da bi ocijenio rad bubrega Vašeg djeteta.
English: • children and adolescents aged 2 to less than 18 years.
Croatian: • odraslih • djece i adolescenata u dobi od 2 do manje od 18 godina.
English: While taking Viread you may still develop infections or other illnesses associated with HIV infection.
Croatian: I tijekom uzimanja Vireada može doći do razvoja infekcija i drugih bolesti povezanih s infekcijom virusom HIV-a.
English: Table 10: Mean (± SD) tenofovir pharmacokinetic parameters by age groups for paediatric patients
Croatian: Tablica 10: Srednje (± SD) vrijednosti farmakokinetičkih parametara tenofovira po dobnim skupinama pedijatrijskih bolesnika
English: • diarrhoea, being sick (vomiting), feeling sick (nausea), dizziness, rash, feeling weak Tests may also show:
Croatian: • proljev, povraćanje, mučnina, omaglica, osip, slabost Pretrage mogu također pokazati:
English: 1 tablet each day with food (for example, a meal or a snack).
Croatian: 1 tableta svaki dan s hranom (na primjer s obrokom ili užinom).